Kieren Mather

24PUBLICATIONS
44CO-AUTHORS
PharmacogenomicsPharmaceutical delivery technologiesGene and molecular therapyRadiation therapyPsychological methodology, design and analysis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jun 02, 2026
Insulin Sensitivity and Beta Cell Function With Macupatide Alone or With Dulaglutide in Type 2 Diabetes: A Phase 1b, Randomised Controlled Trial.

|Jan 21, 2026
Eloralintide, a selective, long-acting amylin receptor agonist for treatment of obesity: Phase 1 proof of concept.

Shobha Bhattachar, Lai San Tham, Beth Tidemann-Miller

|Aug 20, 2025
Mazdutide reduces body weight in adults with overweight or obesity: A high-dose Phase 1 trial.

Shobha N Bhattachar, Lai San Tham, Yan Li

|Aug 14, 2025
Orforglipron, an oral non-peptide glucagon-like peptide-1 receptor agonist, improves markers of β-cell function and insulin sensitivity in type 2 diabetes.

Julio Rosenstock, Deborah A Robins, Kevin L Duffin

|Aug 14, 2025
A Post-Hoc Analysis of Depressive Disorders in Patients with Type 2 Diabetes.

Yegan Pillay, W Guyton Hornsby, Chandan K Saha

|Jan 06, 2025
Greater improvement in insulin sensitivity per unit weight loss associated with tirzepatide versus semaglutide: An exploratory analysis.

Kieren J Mather, Andrea Mari, Govinda Weerakkody

Pageof 4

Frequent Collaborators

5 joint publications

Susan Sam

5 joint publications

Tamara S Hannon

5 joint publications

Steven E Kahn

5 joint publications

Axel Haupt